Yanhua Xu

525 total citations
30 papers, 426 citations indexed

About

Yanhua Xu is a scholar working on Surgery, Endocrinology, Diabetes and Metabolism and Cancer Research. According to data from OpenAlex, Yanhua Xu has authored 30 papers receiving a total of 426 indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Surgery, 20 papers in Endocrinology, Diabetes and Metabolism and 11 papers in Cancer Research. Recurrent topics in Yanhua Xu's work include Diabetes, Cardiovascular Risks, and Lipoproteins (20 papers), Lipoproteins and Cardiovascular Health (14 papers) and Cancer, Lipids, and Metabolism (11 papers). Yanhua Xu is often cited by papers focused on Diabetes, Cardiovascular Risks, and Lipoproteins (20 papers), Lipoproteins and Cardiovascular Health (14 papers) and Cancer, Lipids, and Metabolism (11 papers). Yanhua Xu collaborates with scholars based in China, United States and Saudi Arabia. Yanhua Xu's co-authors include Mingde Fu, Lianqun Jia, Bingyu Yan, Shiyin Long, Lantu Gou, Li Tian, Ying Tian, Ying Tian, Haoming Tian and Li Tian and has published in prestigious journals such as Journal of Clinical Oncology, Acta Biomaterialia and American Heart Journal.

In The Last Decade

Yanhua Xu

29 papers receiving 422 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yanhua Xu China 13 256 226 118 80 53 30 426
Anne Cogny France 10 157 0.6× 201 0.9× 74 0.6× 56 0.7× 51 1.0× 12 425
Veronika Binder Norway 9 178 0.7× 158 0.7× 69 0.6× 56 0.7× 57 1.1× 12 527
P. Fievet France 6 232 0.9× 221 1.0× 60 0.5× 96 1.2× 50 0.9× 9 394
Tse‐Ya Yu Taiwan 10 138 0.5× 128 0.6× 64 0.5× 25 0.3× 77 1.5× 14 363
Katerina Tosheska Trajkovska North Macedonia 9 93 0.4× 126 0.6× 46 0.4× 40 0.5× 42 0.8× 38 332
Rohini Rao United States 6 96 0.4× 134 0.6× 103 0.9× 38 0.5× 33 0.6× 8 366
Andreas Melidonis Greece 10 112 0.4× 92 0.4× 115 1.0× 23 0.3× 48 0.9× 16 444
Haruo Takeda Japan 12 87 0.3× 104 0.5× 43 0.4× 38 0.5× 33 0.6× 43 342
Doina Dimulescu Romania 10 60 0.2× 92 0.4× 155 1.3× 139 1.7× 43 0.8× 18 396
Erhan Onuk Türkiye 14 142 0.6× 184 0.8× 34 0.3× 49 0.6× 64 1.2× 31 485

Countries citing papers authored by Yanhua Xu

Since Specialization
Citations

This map shows the geographic impact of Yanhua Xu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yanhua Xu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yanhua Xu more than expected).

Fields of papers citing papers by Yanhua Xu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yanhua Xu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yanhua Xu. The network helps show where Yanhua Xu may publish in the future.

Co-authorship network of co-authors of Yanhua Xu

This figure shows the co-authorship network connecting the top 25 collaborators of Yanhua Xu. A scholar is included among the top collaborators of Yanhua Xu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yanhua Xu. Yanhua Xu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Li, Jian, Ping Chi, Yoon‐Koo Kang, et al.. (2024). Phase 1 study of NB003, a broad-spectrum KIT/PDGFRα inhibitor, in patients with advanced gastrointestinal stromal tumors (GIST).. Journal of Clinical Oncology. 42(16_suppl). 11518–11518. 5 indexed citations
3.
Wei, Shunbo, Yanhua Xu, Zhiwei Wang, et al.. (2021). Hydrogel-coated needles prevent puncture site bleeding. Acta Biomaterialia. 128. 305–313. 22 indexed citations
4.
Bai, Hualong, Peng Sun, Shunbo Wei, et al.. (2021). A novel intramural TGF β 1 hydrogel delivery method to decrease murine abdominal aortic aneurysm and rat aortic pseudoaneurysm formation and progression. Biomedicine & Pharmacotherapy. 137. 111296–111296. 17 indexed citations
5.
Xu, Yanhua, Zhiju Wang, Shunbo Wei, et al.. (2021). Hydrogel-coated needles prevent puncture site bleeding in arteriovenous fistula and arteriovenous grafts in rats. Biomedicine & Pharmacotherapy. 143. 112113–112113. 5 indexed citations
6.
Liu, Chunyang, Yanhua Xu, Hong Yang, & Jianhua Zhang. (2019). Establishment of axon regeneration regulatory network and the role of low intensity pulsed ultrasound in the network. Saudi Journal of Biological Sciences. 26(8). 1922–1926. 2 indexed citations
7.
Tian, Li, Shiyin Long, Mingde Fu, et al.. (2011). Characteristics of High-density Lipoprotein Subclasses Distribution for Subjects with Desirable Total Cholesterol Levels. Lipids in Health and Disease. 10(1). 64–64. 7 indexed citations
9.
Tian, Li, Jin Wu, Mingde Fu, Yanhua Xu, & Lianqun Jia. (2009). Relationship between apolipoprotein C-III concentrations and high-density lipoprotein subclass distribution. Metabolism. 58(5). 668–674. 8 indexed citations
10.
Jia, Lianqun, Xinwei Wu, Mingde Fu, et al.. (2007). Relationship between apolipoproteins and the alteration of HDL subclasses in hyperlipidemic subjects. Clinica Chimica Acta. 383(1-2). 65–72. 7 indexed citations
11.
Tian, Li, Mingde Fu, Lianqun Jia, et al.. (2007). Relationship Between Apolipoprotein Concentrations and HDL Subclasses Distribution. Lipids. 42(5). 419–426. 7 indexed citations
12.
Tian, Li, Xinwei Wu, Mingde Fu, et al.. (2007). Relationship between plasma apolipoproteinB concentrations, apolipoproteinB/apolipoproeinA-I and HDL subclasses distribution. Clinica Chimica Acta. 388(1-2). 148–155. 13 indexed citations
13.
Jia, Lianqun, Mingde Fu, Ying Tian, et al.. (2006). Alterations of high-density lipoprotein subclasses in hypercholesterolemia and combined hyperlipidemia. International Journal of Cardiology. 120(3). 331–337. 12 indexed citations
15.
Long, Shiyin, Ying Tian, Rong Zhang, et al.. (2005). Relationship between plasma HDL subclasses distribution and lipoprotein lipase gene HindIII polymorphism in hyperlipidemia. Clinica Chimica Acta. 366(1-2). 316–321. 19 indexed citations
16.
Jia, Lianqun, et al.. (2005). Relationship between plasma HDL subclasses distribution and apoA-I gene polymorphisms. Clinica Chimica Acta. 360(1-2). 37–45. 18 indexed citations
17.
Gou, Lantu, et al.. (2005). Alterations of high-density lipoprotein subclasses in endogenous hypertriglyceridemia. American Heart Journal. 150(5). 1039–1045. 31 indexed citations
18.
Yan, Bingyu, et al.. (2004). Relationship between plasma lipid concentrations and HDL subclasses. Clinica Chimica Acta. 354(1-2). 49–58. 43 indexed citations
19.
Xu, Yanhua & Mingde Fu. (2003). Alterations of HDL subclasses in hyperlipidemia. Clinica Chimica Acta. 332(1-2). 95–102. 48 indexed citations
20.
Xu, Yanhua. (2003). Relationship between the levels of plasma lipids and the contents of serum HDL subclasses in patients with coronary heart disease. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026